| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Financial Officer | Director | Chief Financial Officer
3 companies
Reed Joshua serves as a Chief Financial Officer at ALDX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 4 sells. Those positions are worth an estimated $1.0M at current prices.
The biggest single holding is SRRK (~$1.0M) as Director. The recent filings there lean toward selling, a net 8,453 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | SRRK Scholar Rock Holding Corporation | Director | Sell10b5-1 | 3,053 | $53.74 | $164,067.43 | -13.5% | -9.6% | - | |
| May 29, 2025 | SRRK Scholar Rock Holding Corp | Director | Sell10b5-1 | 5,400 | $29.72 | $160,462.57 | -25.6% | +15.5% | +65.2% | |
| Sep 5, 2019 | ALDX Aldeyra Therapeutics, Inc. | Chief Financial Officer | Buy | 3,200 | $4.71 | $15,072.00 | +9.8% | - | - |